(Q47872223)

English

Differential expression of PDE4 cAMP phosphodiesterase isoforms in inflammatory cells of smokers with COPD, smokers without COPD, and nonsmokers

scientific article published on 26 March 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/15047569

Differential expression of PDE4 cAMP phosphodiesterase isoforms in inflammatory cells of smokers with COPD, smokers without COPD, and nonsmokers (English)

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/15047569

chronic obstructive pulmonary disease

1 reference

based on heuristic

inferred from title

Miles D. Houslay

6

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/15047569

author name string

Rachael Barber

1

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/15047569

George S Baillie

2

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/15047569

Reinhard Bergmann

3

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/15047569

Malcolm C Shepherd

4

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/15047569

Ruth Sepper

5

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/15047569

Gino Van Heeke

7

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/15047569

publication date

26 March 2004

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/15047569

American Journal of Physiology - Lung Cellular and Molecular Physiology

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/15047569

287

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/15047569

2

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/15047569

L332-43

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/15047569

New concepts in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00384.2003

21 January 2018

Cyclic nucleotide research -- still expanding after half a century

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00384.2003

21 January 2018

Attenuation of the activity of the cAMP-specific phosphodiesterase PDE4A5 by interaction with the immunophilin XAP2

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00384.2003

21 January 2018

Recent advances in PDE4 inhibitors as immunoregulators and anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00384.2003

21 January 2018

Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signaling.

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00384.2003

21 January 2018

Update on the therapeutic potential of PDE4 inhibitors

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00384.2003

21 January 2018

Identification of cyclic AMP phosphodiesterases 3, 4 and 7 in human CD4+ and CD8+ T-lymphocytes: role in regulating proliferation and the biosynthesis of interleukin-2

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00384.2003

21 January 2018

Molecular cloning of a novel splice variant of human type IVA (PDE-IVA) cyclic AMP phosphodiesterase and localization of the gene to the p13.2-q12 region of human chromosome 19 [corrected]

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00384.2003

21 January 2018

PDE4 cAMP-specific phosphodiesterases

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00384.2003

21 January 2018

PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00384.2003

21 January 2018

The next generation of PDE4 inhibitors

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00384.2003

21 January 2018

Flock Worker's Lung

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00384.2003

21 January 2018

Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-alpha responses

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00384.2003

21 January 2018

Two distinct regions of the immunophilin-like protein XAP2 regulate dioxin receptor function and interaction with hsp90

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00384.2003

21 January 2018

Identification and quantification of phosphodiesterase 4 subtypes in CD4 and CD8 lymphocytes from healthy and asthmatic subjects

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00384.2003

21 January 2018

Cyclic AMP-dependent transcriptional up-regulation of phosphodiesterase 4D5 in human airway smooth muscle cells. Identification and characterization of a novel PDE4D5 promoter

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00384.2003

21 January 2018

Stimulation of p70S6 kinase via a growth hormone-controlled phosphatidylinositol 3-kinase pathway leads to the activation of a PDE4A cyclic AMP-specific phosphodiesterase in 3T3-F442A preadipocytes

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00384.2003

21 January 2018

Suppression of human inflammatory cell function by subtype-selective PDE4 inhibitors correlates with inhibition of PDE4A and PDE4B.

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00384.2003

21 January 2018

A peripheral and an intrinsic enzyme constitute the cyclic AMP phosphodiesterase activity of rat liver plasma membranes

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00384.2003

21 January 2018

Association with the SRC family tyrosyl kinase LYN triggers a conformational change in the catalytic region of human cAMP-specific phosphodiesterase HSPDE4A4B. Consequences for rolipram inhibition

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00384.2003

21 January 2018

Targeting of cyclic AMP degradation to beta 2-adrenergic receptors by beta-arrestins

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00384.2003

21 January 2018

Deletion of phosphodiesterase 4D in mice shortens alpha(2)-adrenoceptor-mediated anesthesia, a behavioral correlate of emesis

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00384.2003

21 January 2018

Impaired host defense to Klebsiella pneumoniae infection in mice treated with the PDE4 inhibitor rolipram

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00384.2003

21 January 2018

Phosphodiesterase isozymes: molecular targets for novel antiasthma agents

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00384.2003

21 January 2018

Ariflo (SB 207499), a second generation phosphodiesterase 4 inhibitor for the treatment of asthma and COPD: from concept to clinic

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00384.2003

21 January 2018

Identifiers

10.1152/AJPLUNG.00384.2003

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/15047569

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/15047569

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47872223&oldid=2173632903"